PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to control rare liver disease
Disease control TerminatedThis study tested whether combining two drugs, obeticholic acid and bezafibrate, could improve liver health in people with primary biliary cholangitis (PBC) who did not respond well to standard treatment. About 75 adults with PBC were enrolled. The study was stopped early, so res…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
Liver disease drug combo safety check ends early
Disease control TerminatedThis study looked at the long-term safety of a fixed-dose combination of two drugs, obeticholic acid and bezafibrate, in adults with primary biliary cholangitis (PBC), a chronic liver disease. It enrolled 63 participants who had previously been in related studies. The study was t…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:51 UTC